InvestSMART

4DMedical Limited (ASX: 4DX) - Announcements

Current share price for 4DX : $4.100 0.02 (0.49%)+

ASX company news and announcements for 4DMedical Limited (4DX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All 4DMedical Limited (4DX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than 4DMedical Limited (4DX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for 4DMedical Limited (4DX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$2,467 4DMedical appoints Dr Geraldine McGinty to board 25 Sep 2023 9:14AM $0.530 $4.100 risen by 673.58%
$2,467 Investor Presentation 11 Sep 2023 4:11PM $0.590 $4.100 risen by 594.92%
$2,467 Application for quotation of securities - 4DX 6 Sep 2023 3:00PM $0.615 $4.100 risen by 566.67%
$2,467 S&P DJI Announces September 2023 Quarterly Rebalance 1 Sep 2023 5:02PM $0.645 $4.100 risen by 535.66%
$2,467 Appendix 3Y 1 Sep 2023 3:11PM $0.650 $4.100 risen by 530.77%
$2,467 Notice of AGM Date 29 Aug 2023 11:08AM $0.590 $4.100 risen by 594.92%
$2,467 Appendix 4G 29 Aug 2023 11:02AM $0.590 $4.100 risen by 594.92%
$2,467 Corporate Governance Statement 29 Aug 2023 11:00AM $0.590 $4.100 risen by 594.92%
$2,467 FY2023 Full Year Results 29 Aug 2023 10:46AM $0.610 $4.100 risen by 572.13%
$2,467 Annual Report and Appendix 4E 29 Aug 2023 10:41AM $0.610 $4.100 risen by 572.13%
$2,467 Notification regarding unquoted securities - 4DX 15 Aug 2023 9:48AM $0.725 $4.100 risen by 465.52%
$2,467 Notification of cessation of securities - 4DX 8 Aug 2023 9:29AM $0.630 $4.100 risen by 550.79%
$2,467 Statement pursuant to Listing Rule 4.7C.3 2 Aug 2023 12:38PM $0.690 $4.100 risen by 494.20%
$2,467 Quarterly Activity Report and Appendix 4C for Q4 FY2023 31 Jul 2023 9:26AM $0.735 $4.100 risen by 457.82%
$2,467 4DMedical wins $1.1 million CTCM funding 24 Jul 2023 9:34AM $0.685 $4.100 risen by 498.54%
$2,467 Notification regarding unquoted securities - 4DX 15 Jun 2023 12:22PM $0.795 $4.100 risen by 415.72%
$2,467 Results of Meeting 14 Jun 2023 1:39PM $0.825 $4.100 risen by 396.97%
$2,467 EGM presentation and CEO address 14 Jun 2023 9:23AM $0.825 $4.100 risen by 396.97%
$2,467 Change in substantial holding 31 May 2023 2:25PM $0.780 $4.100 risen by 425.64%
$2,467 Change in substantial holding 31 May 2023 2:23PM $0.780 $4.100 risen by 425.64%
$2,467 Change in substantial holding 31 May 2023 2:21PM $0.780 $4.100 risen by 425.64%
$2,467 Application for quotation of securities - 4DX 30 May 2023 11:14AM $0.835 $4.100 risen by 391.02%
$2,467 Update - Proposed issue of securities - 4DX 29 May 2023 2:32PM $0.860 $4.100 risen by 376.74%
$2,467 4DMedical completes oversubscribed $25m SPP 29 May 2023 1:30PM $0.850 $4.100 risen by 382.35%
$2,467 44Medical unveils VQ product at premier US lung conference 23 May 2023 9:18AM $0.910 $4.100 risen by 350.55%

376 - 400 of 603 results

Page 16 of 25

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.